null

Iscalimab (Anti-CD40) Biosimilar Antibody

SKU:
HDBS0020
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CD40
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-CD40 iscalimab biosimilarmAb HDBS0020
  • Anti-CD40 iscalimab biosimilarmAb HDBS0020
  • Anti-CD40 iscalimab biosimilarmAb HDBS0020
$448
Frequently bought together:

Description

system_update_altDatasheet

Iscalimab (Anti-CD40) Biosimilar Antibody (HDBS0020)

The Anti-CD40 (IscaImab) Biosimilar MAB-HDBS0020 is a cutting-edge monoclonal antibody designed for research applications involving CD40, a cell surface protein implicated in immune activation and inflammation. This antibody, produced through a biosimilar process, shows high specificity and reactivity with CD40 in human samples, making it an excellent tool for various immunoassays and immunochemical techniques.CD40 is a key regulator of immune responses, playing a crucial role in the activation of T cells and B cells, as well as promoting inflammation and antibody production. Dysregulation of CD40 signaling has been implicated in various autoimmune diseases, inflammatory disorders, and cancer progression, making it a promising target for therapeutic intervention.

The Anti-CD40 (IscaImab) Biosimilar MAB-HDBS0020 binds specifically to CD40, enabling researchers to study its function and activity in different cell types and biological systems. Its use in studies related to immunology, oncology, and inflammatory diseases can provide valuable insights into the mechanisms underlying these conditions and potentially lead to the development of novel treatment strategies.Overall, the Anti-CD40 (IscaImab) Biosimilar MAB-HDBS0020 is a reliable and effective tool for investigating the role of CD40 in immune regulation and disease pathogenesis, offering researchers a valuable resource for advancing their understanding of immune responses and developing targeted therapies for related conditions.